Navigation Links
Ingenuity Systems and Affymetrix Partner to Eliminate Microarray Expression Analysis Bottleneck
Date:4/8/2013

REDWOOD CITY, Calif. and SANTA CLARA, Calif., April 8, 2013 /PRNewswire/ -- Ingenuity® Systems, a leading provider of biomedical information and analysis solutions, and Affymetrix®, Inc. (NASDAQ: AFFX) today announced that they will co-promote Ingenuity® iReport™ with Affymetrix expression microarray products effectively eliminating a bottleneck for researchers working with human, mouse and rat applications by coupling a fast and accurate statistical analysis and biological interpretation workflow with the gold-standard platform for gene expression studies.

Affymetrix expression microarrays are the standard methodology used for many research and discovery applications and when combined with Ingenuity iReport, an interactive web-based report that leverages the Ingenuity Knowledge Base of biological and chemical findings from the peer reviewed literature and databases, deliver researchers a 'sample to insight' continuous workflow allowing for rapid, confident interpretation of results without the need for bioinformatics experience or support. 

"We are excited to partner with Ingenuity Systems to provide our array users with access to the intuitive biological and statistical analysis platform offered by iReport," said Kevin Cannon , Ph.D., SVP - Expression Business Unit at Affymetrix. "Bundling together our robust expression microarrays with the iReport platform will provide Affymetrix' customers with a simple and accurate tool to convert data into biologically relevant results."

"By leveraging Ingenuity iReport with Affymetrix gene expression arrays for our study on a mouse model of Familial Hypertrophic Cardiomyopathy, we accelerated our data interpretation several-fold compared to using other analysis tools. Their rapid and effectively-blind analysis provided an unbiased validation of our data. Additionally, iReport allowed us to identify and explore genes of interest found with Affymetrix gene chips, yet not identified by other analysis tools," said Adrian Grimes , Ph.D., from the Department of Pediatrics at the University of Wisconsin.

About Ingenuity® Systems

Ingenuity® Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems in life science research and molecular diagnostics. Today, Ingenuity's solutions are used by tens of thousands of researchers and clinicians at hundreds of leading pharmaceutical, biotechnology, academic, diagnostic and clinical institutions worldwide.

About Affymetrix

Affymetrix' technologies are used by the world's top pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and non-profit research institutes. More than 2,300 microarray systems have been shipped around the world and more than 48,000 peer-reviewed papers have been published citing our technologies. Affymetrix is headquartered in Santa Clara, California, and has manufacturing facilities in Cleveland, Ohio, San Diego, Vienna and Singapore. The Company has about 1,100 employees worldwide and maintains sales and distribution operations across Europe, Asia, and Latin America. For more information about Affymetrix, please visit www.affymetrix.com.

PLEASE NOTE: Affymetrix® and the Affymetrix logo are the property of Affymetrix, Inc. All other trademarks are the property of their respective owners.

Products mentioned in this release are for research use only. Not for diagnostic procedures.


'/>"/>
SOURCE Ingenuity Systems
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Ingenuity Systems IPA Provides Researchers with Genomic Insights Suggesting that Physical Activity Does Not Slow Muscle Aging
2. Ingenuity Systems and GeneInsight to Deliver an Interpretation and Reporting Workflow Solution to Clinical Laboratories
3. Ingenuity Systems Announces Curation of All Human Disease Implicated Genetic Variation
4. Ingenuity Systems Announces Compliance with HIPAA
5. Suspect Detection Systems Receives Funding From Israel-Publicly Traded Biomedix Ltd.
6. First Warning Systems, Inc., Appoints Veteran Medical Executive Royea as CEO
7. R&D Systems is Offering Travel Grants to Attend the 15th International Congress of Immunology
8. Pharmacy Automation Systems Market is Expected to Reach USD 7.8 Billion by 2018: Transparency Market Research
9. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
10. Point-of-Delivery Drug. Reconstitution Systems Markets, Strategies and Prospects
11. Genomics Data Management Leader Annai Systems Offers Shortcut to Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2019)... ... , ... In this live webinar, the featured speakers will focus on the ... Participants will learn how to use the information they have from the protocol and ... complex randomization scheme is properly designed and set up to ensure flawless execution. As ...
(Date:3/5/2019)... ... March 05, 2019 , ... San Fransisko, or Sisko for short, ... at four years old to pursue a career in dressage. According to Deborah, ... talented horse that she’d ever worked with. Unfortunately, Sisko suffered an injury while ...
(Date:2/27/2019)... ... February 26, 2019 , ... Superior Controls, Inc., a ... with 140 employees on both the east and west coasts, today announced that ... of New Hampshire. Sandmaier, a senior project engineer, joins Taggart McCormick, P.E., Anthony ...
(Date:2/22/2019)... ... February 20, 2019 , ... Ocean Tomo Transactions, LLC ... , The patents in lot 92 relate to innovation for ... distinguish between human users and computers through exploiting the fundamental differences between computer-based ...
Breaking Biology Technology:
(Date:3/9/2019)... ... 2019 , ... Hello Bio announces the launch of novel ... studying GPCR and DREADD signalling. Hello Bio has been granted a license from ... and Stroke, both institutes of the National Institutes of Health, as well as ...
(Date:3/1/2019)... ... March 01, 2019 , ... Geneious would like to announce it is ... to Vector NTI. , Geneious Prime already has a dedicated importer for Vector ... so that files will be organised in Geneious in the same way. The ...
(Date:2/27/2019)... ... February 27, 2019 , ... Fluxion Biosciences, a leading developer of ... a National Cancer Institute grant for further development of its ERASE-Seq liquid biopsy technology. ... from the lab of Dr. Omar Mian at the Cleveland Clinic. , Liquid biopsies ...
Breaking Biology News(10 mins):